mRNA Levels of Telomerase in Brain Tumors
Author Information
Author(s): Yannopoulos A, Dimitriadis E, Scorilas A, Trangas T, Markakis E, Talieri M
Primary Institution: University Hospital of Heraclio
Hypothesis
The study aims to evaluate the mRNA expression of telomerase in different types of intracranial tumors and correlate it with patient outcomes.
Conclusion
Higher levels of hTERT mRNA expression are associated with increased tumor grade and poorer patient survival outcomes.
Supporting Evidence
- Patients with negative hTERT expression had longer progression-free survival.
- Statistical correlation was found between hTERT mRNA levels and tumor grade.
- Patients with positive hTERT expression had a higher risk of relapse.
Takeaway
This study looked at brain tumors and found that those with higher levels of a specific gene related to telomerase had worse survival rates.
Methodology
Real-time quantitative RT–PCR was used to measure hTERT mRNA levels in tumor samples.
Potential Biases
Potential bias may arise from the selection of tumor samples and the lack of prior treatment in patients.
Limitations
The study's findings may not be generalizable due to the specific population studied and the small sample sizes in some tumor categories.
Participant Demographics
Patients were from the island of Crete, with ages ranging from 1 to 76 years.
Statistical Information
P-Value
P=0.031 for progression-free survival, P=0.047 for overall survival
Confidence Interval
95% CI for HR=1.046–4.97
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website